Oxidation of LDL, Atherogenesis, and Apoptosis

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 698-709

  Napoli, Claudio ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medicine UN   (Italy)

Author keywords

Apoptosis; Atherosclerosis; Lipoperoxidation; Lipoproteins

Indexed keywords

CASPASE; LOW DENSITY LIPOPROTEIN; PROTEIN BCL 2; PROTEINASE;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; NECROSIS; PROTEIN EXPRESSION;

EID: 1342284233     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.127     Document Type: Conference Paper

References (106)

1. ROSS, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
2. NAPOLI, C. & W. PALINSKI. 2001. Clinical and pathogenic implications of maternal hypercholesterolemia during pregnancy for the later development of atherosclerosis. Eur. Heart J. 22: 4-9.
3. DE NIGRIS, F., L.O. LERMAN, M. CONDORELLI et al. 2001. Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall. Antioxidant Redox Signal. 3: 1119-1130.
4. PALINSKI, W. & C. NAPOLI. 2002. The fetal origins of atherosclerosis: maternal hypercholesterolemia and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and post-natal susceptibility to the disease. FASEB J. 16: 1348-1360.
5. GENG, Y.J. 2001. Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr. Atheroscler. Rep. 3: 234-242.
6. KOCKX, M.M., G.R. DE MEYER, J. MUHRING et al. 1998. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97: 2307-2315.
7. GENG, Y.J. & P. LIBBY. 1995. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am. J. Pathol. 147: 251-266.
8. SUH, Y. 2002. Cell signaling in aging and apoptosis. Mech. Ageing Dev. 123: 881-890.
9. DIMMELER, S., J. HAENDELER, V. RIPPMANN et al. 1996. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 399: 71-74.
10. DIMMELER, S., J. HAENDELER, M. NEHLS & A.M. ZEIHER. 1997. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β- converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185: 601-607.
11. URBICH, C., D.H. WALTER, A.M. ZEIHER & S. DIMMELER. 2000. Laminar shear stress upregulates integrin expression: role in endothelial cell adhesion and apoptosis. Circ. Res. 87: 683-689.
12. GLASS, C.K. & J.L. WITZTUM. 2001. Atherosclerosis: the road ahead. Cell 104: 503-516.
13. LANGLEY, R.E., E.A. BUMP, S.G. QUARTUCCIO et al. 1997. Radiation-induced apoptosis in microvascular endothelial cells. Br. J. Cancer 75: 666-672.
14. LOPEZ-CANDALES, A., D.R. HOLMES, M.J. SCOTT et al. 1996. Effects of ultraviolet light in vascular cells in vitro and in intact atherosclerotic explants: potential role of apoptosis in vascular biology. Biochem. Cell Biol. 74: 333-345.
15. JOHNSON, T.M., Z.X. YU, V.J. FERRANS et al. 1996. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 93: 11848-11852.
16. PATEL, R.P., D. MOELLERING, J. MURPHY-ULLRICH et al. 2000. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radical Biol. Med. 28: 1780-1794.
17. NISHIO, E. & Y. WATANABE. 1996. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem. Biophys. Res. Commun. 226: 928-934.
18. HARADA-SHIBA, M., M. KINOSHITA, H. KAMIDO & K. SHIMOKADO. 1998. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 273: 9681-9687.
19. LIAO, H.S., T. KODAMA & Y.J. GENG. 2000. Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol. Arterioscler. Thromb. Vasc. Biol. 20: 1968-1975.
20. KOVACS, A., M.L. WEBER, L.J. BURNS et al. 1996. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 149: 1531-1539.
21. SELA, D.D., M. KORNER, M. PICK et al. 1996. Programmed endothelial cell death induced by an avian hemangioma retrovirus is density dependent. Virology 223: 233-237.
22. HAENDELER, J., A.M. ZEIHER & S. DIMMELER. 1996. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur. J. Pharmacol. 317: 407-411.
23. GENG, Y.J., Q. WU, M. MUSZYNSKI et al. 1996. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta. Arterioscler. Thromb. Vasc. Biol. 16: 19-27.
24. HENDERSON, E.L., Y.J. GENG, G.K. SUKHOVA et al. 1999. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99: 96-104.
25. ASHKENAZI, A. & V.M. DIXIT. 1998. Death receptors: signaling and modulation. Science 281: 1305-1308.
26. GENG, Y.J., L.E. HENDERSON, E.B. LEVESQUE et al. 1997. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17: 2200-2208.
27. CAI, W., B. DEVAUX, W. SCHAPER & J. SCHAPER. 1997. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131: 177-186.
28. WALSH, K. & M. SATA. 1999. Is extravasation a Fas-regulated process? Mol. Med. Today 5: 61-67.
29. SCHNEIDER, D.B., G. VASSALLI, S. WEN et al. 2000. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 20: 298-308.
30. SCHAUB, F.J., D.K. HAN, W.C. LILES et al. 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6: 790-796.
31. NAPOLI, C., F.P. D'ARMIENTO, F.P. MANCINI et al. 1997. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimai accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100: 2680-2690.
32. NAPOLI, C., J.L. WITZTUM, F. DE NIGRIS et al. 1999. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 99: 2003-2010.
33. NAPOLI, C., C.K. GLASS, J.L. WITZTUM et al. 1999. Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) Study. Lancet 354: 1234-1241.
34. KELLNER-WEIBEL, G., Y.J. GENG & G.H. ROTHBLAT. 1999. Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane. Atherosclerosis 146: 309-319.
35. HEERMEIER, K., R. SCHNEIDER, A. HEINLOTH et al. 1999. Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a). Kidney Int. 56: 1310-1312.
36. ESCARGUEIL-BLANC, I., N. ANDRIEU-ABADIE, S. CASPAR-BAUGUIL et al. 1998. Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells. J. Biol. Chem. 273: 27389-27395.
37. DIMMELER, S., J. HAENDELER, J. GALLE & A.M. ZEIHER. 1997. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the "response to injury" hypothesis. Circulation 95: 1760-1763.
38. SATA, M. & K. WALSH. 1998. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J. Clin. Invest. 102: 1682-1689.
39. GARRINGTON, T.P. & G.L. JOHNSON. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211-218.
40. NAPOLI, C., O. QUEHENBERGER, F. DE NIGRIS et al. 2000. Mildly oxidized low-density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14: 1996-2007.
41. DE NIGRIS, F., F. FRANCONI, I. MAIDA et al. 2000. Modulation by α-and γ-tocopherol of apoptotic signaling induced by oxidized low-density lipoprotein in human coronary smooth muscle cells. Biochem. Pharmacol. 59: 1477-1487.
42. FUSTER, V., B. STEIN, J.A. AMBROSE et al. 1990. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 82(suppl. II): II47-II59.
43. LIBBY, P. 1995. Molecular bases of the acute coronary syndromes. Circulation 91: 2844-2850.
44. BOMBELI, T., A. KARSAN, J.F. TAIT & J.M. HARLAN. 1997. Apoptotic vascular endothelial cells become procoagulant. Blood 89: 2429-2442.
45. FLYNN, P.D., C.D. BYRNE, T.P. BAGLIN et al. 1997. Thrombin generation by apoptotic vascular smooth muscle cells. Blood 89: 4378-4384.
46. PALINSKI, W. & C. NAPOLI. 2002 Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler. Thromb. Vasc. Biol. 22: 1745-1750.
47. HOLMES, D.R., C.A. LOPEZ, S. LIAO & R.W. THOMPSON. 1996. Smooth muscle cell apoptosis and p53 expression in human abdominal aortic aneurysms. Ann. N.Y. Acad. Sci. 800: 286-287.
48. HENDERSON, E.L., Y.J. GENG, G.K. SUKHOVA et al. 1999. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99: 96-104.
49. PALINSKI, W. & J.L. WITZTUM. 2000. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247: 371-380.
50. BINDER, C.J., M.K. CHANG, P.X. SHAW et al. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8: 1218-1226.
51. SALVAYRE, R., N. AUGE, H. BENOIST & A. NEGRE-SALVAYRE. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585: 213-221.
52. HANSSON, G.K., Y.J. GENG, J. HOLM et al. 1994. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180: 733-738.
53. GENG, Y.J., A.S. PETERSSON, A. WENNMALM & G.K. HANSSON. 1994. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp. Cell Res. 214: 418-428.
54. IGNARRO, L.J., G. CIRINO, A. CASINI & C. NAPOLI. 1999. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34: 876-884.
55. NAPOLI, C. & L.J. IGNARRO. 2001. Nitric oxide and atherosclerosis. Nitric Oxide 5: 88-97.
56. PATEL, R.P., D. MOELLERING, J. MURPHY-ULLRICH et al. 2000. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radical Biol. Med. 28: 1780-1794.
57. DE NIGRIS, F., L.O. LERMAN, S. WILLIAMS-IGNARRO et al. 2003. Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial nitric oxide synthase activity at the sites of disturbed shear stress. Proc. Natl. Acad. Sci. USA 100: 1420-1425.
58. DIMMELER, S., V. RIPPMANN, U. WEILAND et al. 1997. Angiotensin II induces apoptosis of human endothelial cells: protective effect of nitric oxide. Circ. Res. 81: 970-976.
59. NAPOLI, C. & L.J. IGNARRO. 2003. Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol. 47: 97-123.
60. NAPOLI, C., E. ACKAH, F. DE NIGRIS et al. 2002. Chronic treatment with nitric oxide-releasing aspirin inhibits plasma LDL oxidation and oxidative stress, oxidation-specific epitopes in the arterial wall, and atherogenesis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 99: 12467-12470.
61. PIKE, A.C., A.M. BRZOZOWSKI, S.M. ROBERTS et al. 1999. Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc. Natl. Acad. Sci. USA 96: 8925-8930.
62. TOSCHI, V., G. GALLO, M. LETTINO et al. 1997. Tissue factor modulates thrombogenicity of human atherosclerotic plaques. Circulation 95: 594-599.
63. BADIMON, J.J., M. LETTINO, V. TOSCHI et al. 1999. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99: 1780-1787.
64. BACH, R. & D.B. RIFKIN. 1990. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc. Natl. Acad. Sci. USA 87: 6995-6999.
65. MALLAT, Z., B. HUGEL, J. OHAN et al. 1999. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99: 348-353.
66. VAN DER WAL, A.C., A.E. BECKER, C.M. VAN DER LOOS & P.K. DAS. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44.
67. KOLODGIE, F.D., J. NARULA, A.P. BURKE et al. 2000. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157: 1259-1268.
68. BAURIEDEL, G., R. HUTTER, U. WELSCH et al. 1999. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41: 480-488.
69. FARB, A., A.P. BURKE, A.L. TANG et al. 1996. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 93: 1354-1363.
70. BURKE, A.P., A. FARB, G.T. MALCOM et al. 1997. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med. 336: 1276-1288.
71. TRICOT, O., Z. MALLAT, C. HEYMES et al. 2000. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101: 2450-2453.
72. LEDRU, F., P. THEROUX, J. LESPERANCE et al. 1999. Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J. Am. Coll. Cardiol. 33: 1353-1361.
73. SCHAUB, F.J., D.K. HAN, W.C. LILES et al. 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6: 790-796.
74. POLLMAN, M.J., J.L. HALL, M.J. MANN et al. 1998. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med. 4: 222-227.
75. KAISER, D., M.A. FREYBERG & P. FRIEDL. 1997. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem. Biophys. Res. Commun. 231: 586-590.
76. KUBO, N., J. KIKUCHI, Y. FURUKAWA et al. 1997. Regulatory effects of aggregated LDL on apoptosis during foam cell formation of human peripheral blood monocytes. FEBS Lett. 409: 177-182.
77. BENNETT, M.R., G.I. EVAN & S.M. SCHWARTZ. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95: 2266-2274.
78. KATOH, O., H. TAUCHI, K. KAWAISHI et al. 1995. Expression of the vascular endothelial growth factor (VEGF): effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 55: 5687-5692.
79. FOX, J.C. & J.R. SHANLEY. 1996. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J. Biol. Chem. 271: 12578-12584.
80. ARAKI, S., Y. SIMADA, K. KAJI & H. HAYASHI. 1990. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem. Biophys. Res. Commun. 172: 1081-1085.
81. SIOW, R.C., H. SATO, D.S. LEAKE et al. 1999. Induction of antioxidant stress proteins in vascular endothelial and smooth muscle cells: protective action of vitamin C against atherogenic lipoproteins. Free Radical Res. 31: 309-318.
82. LIZARD, G., S. GUELDRY, O. SORDET et al. 1998. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 12: 1651-1663.
83. LI, P.F., R. DIETZ & R. VON HARSDORF. 1997. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96: 3602-3609.
84. EVAN, G. & T. LITTLEWOOD. 1998. A matter of life and cell death. Science 281: 1317-1322.
85. NAPOLI, C., L.O. LERMAN, F. DE NIGRIS & V. SICA. 2002. c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases? Neoplasia 4: 185-190.
86. DE NIGRIS, F., T. YOUSSEF, S. CIAFRE et al. 2000. Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation 102: 2111-2117.
87. DE NIGRIS, F., L.O. LERMAN, M. RODRIGUEZ-PORCEL et al. 2001. c-Myc activation in early coronary lesions in experimental hypercholesterolemia. Biochem. Biophys. Res. Commun. 241: 945-950.
88. BENNETT, M.R., G.I. EVAN & A.C. NEWBY. 1994. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res. 74: 525-536.
89. VON DER THUSEN, J.H., B.J. VAN VLIJMEN, R.C. HOEBEN et al. 2002. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105: 2064-2070.
90. CHANG, M.K., C.J. BINDER, M. TORZEWSKI & J.L. WITZTUM. 2002. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorycoline of oxidized phospholipids. Proc. Natl. Acad. Sci. USA 99: 13043-13048.
91. SUZUKI, J., M. ISOBE, R. MORISHITA et al. 2000. Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts. Cardiovasc. Res. 45: 783-787.
92. NAPOLI, C., F. DE NIGRIS & W. PALINSKI. 2001. Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82: 674-682.
93. DE NIGRIS, F., L.O. LERMAN & C. NAPOLI. 2002. New insights in the transcriptional activity and coregulator molecules in the arterial wall. Int. J. Cardiol. 86: 153-168.
94. SCHROEPFER, G.J., JR. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80: 361-354.
95. KITADA, S., S. KRAJEWSKI, T. MIYASHITA et al. 1996. Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12: 187-192.
96. MATTURRI, L., A. CAZZULLO, P. TURCONI et al. 2000. Inflammatory cells, apoptosis, and Chlamydiapneumoniae infection in atherosclerosis. Int. J. Cardiol. 75: 23-33.
97. JEREMY, J.Y., D. ROWE, A.M. EMSLEY & A.C. NEWBY. 1999. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc. Res. 43: 580-594.
98. NEWBY, A.C. & S.J. GEORGE. 1996. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr. Opin. Cardiol. 11: 574-582.
99. REINMUTH, N., W. LIU, Y.D. JUNG et al. 2001. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 15: 1239-1241.
100. KONDO, S., Y. KONDO, D. YIN et al. 1996. Involvement of interleukin-1β-converting enzyme in apoptosis of bFGF-deprived murine aortic endothelial cells. FASEB J. 10: 1192-1197.
101. BUERKE, M., T. MUROHARA, C. SKURK et al. 1995. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc. Natl. Acad. Sci. USA 92: 8031-8035.
102. TEWARI, M., L.T. QUAN, K. O'ROURKE et al. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809.
103. DATTA, R., D. BANACH, H. KOJIMA et al. 1996. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88: 1936-1943.
104. WANG, C.Y., M.W. MAYO, R.G. KORNELUK et al. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
105. SIOW, R.C., J.P. RICHARDS, K.C. PEDLEY et al. 1999. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler. Thromb. Vasc. Biol. 19: 2387-2394.
106. DE NIGRIS, F., A. LERMAN, L.J. IGNARRO et al. 2003. Oxidation-sensitive mechanisms, vascular apoptosis, and atherosclerosis. Trends Mol. Med. 9: 351-359.